PATENT CLAIM ANALYSIS

Application Number: 16249415
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "490000"]

Abstract:
A particulate, modified release barrier coated drug-cation exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. Methods of making and products containing this coated complex are described.

Claim (Index 15):
The orally ingestible aqueous liquid suspension according to  claim 14 , wherein said cation exchange resin used to form the complex as defined in (A) and/or B(iiia) is a sulfonated copolymer comprising styrene and a divinylbenzene.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 1.21212
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15200748', '13746654', '15619637', '14065842', '15200786']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7037495394883354
- 35 USC 102 Novelty (BERT): 0.5929697717201095
- Combined Prediction Score: 0.6926715627115129
- Mean Citation Score: 489.50740800000005
- Max Citation Score: 496.6725
- Similarity Product: 458.6298360997439

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test